NCT01882400View on ClinicalTrials.gov

Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy

PHASE4CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
OsteoporosisMuscular DystrophyCystic Fibrosis
Interventions
DRUG

Bisphosphonate treatment

Treatment with Calcium, vitamin D and a weekly bisphosphonate. Comparison of bone mass, fracture rate, pain intensity and scoliosis progression before and after treatment

Trial Locations (1)

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

All Listed Sponsors
collaborator

Procter and Gamble

INDUSTRY

lead

Gilles Boire

OTHER

NCT01882400 - Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy | Biotech Hunter | Biotech Hunter